InvestorsHub Logo
Followers 38
Posts 20711
Boards Moderated 1
Alias Born 07/10/2015

Re: boston745 post# 38708

Thursday, 11/17/2022 2:36:46 PM

Thursday, November 17, 2022 2:36:46 PM

Post# of 41615

Currently, Si3N4 is already being used in arthrodesis devices in the cervical and thoracolumbar spine, and it is under consideration for approval in the joint arthroplasty and dental fields.



Anyone wish to discuss this? Whom is it that has submitted joint & dental related si3n4 products to a regulatory agency? Sintx cant produce either product alone, instead manufacturing components of each. So whom submitted these?

Scientists and engineers have made great strides in expanding the use of Si3N4 for clinical applications and addressing various issues being faced by the industry today. Si3N4 has the potential to be microstructurally engineered and adapted to many applications, e.g., by grain size and morphology, grain boundary phase, or in a composite. We expect that further innovation of Si3N4 will come soon.


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224221

Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News